Detalles de la búsqueda
1.
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Blood
; 143(2): 152-165, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37832030
2.
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
BMC Cancer
; 24(1): 370, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38528445
3.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.
Br J Haematol
; 202(4): 749-759, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36257914
4.
Pilot study of lung cancer screening for survivors of Hodgkin lymphoma.
Haematologica
; 2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37981893
5.
Personalised therapy in follicular lymphoma - is the dial turning?
Hematol Oncol
; 2023 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37482955
6.
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing.
Am J Hematol
; 98(5): 750-759, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36866925
7.
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.
Lancet
; 398(10306): 1157-1169, 2021 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34508654
8.
The perspectives of survivors of Hodgkin lymphoma on lung cancer screening: A qualitative study.
Health Expect
; 25(1): 116-124, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34755419
9.
Likely uptake of a future a lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study.
BMC Pulm Med
; 22(1): 165, 2022 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484621
10.
The development of a decision aid to support Hodgkin lymphoma survivors considering lung cancer screening.
BMC Med Inform Decis Mak
; 22(1): 29, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35105364
11.
Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approaches.
Br J Haematol
; 195(2): 162-173, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33783838
12.
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY).
Br J Haematol
; 193(1): 63-71, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32926420
13.
Immune infiltrate diversity confers a good prognosis in follicular lymphoma.
Cancer Immunol Immunother
; 70(12): 3573-3585, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33929583
14.
Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma.
Br J Cancer
; 122(4): 539-544, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31806878
15.
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.
Br J Haematol
; 189(5): 879-887, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31997308
16.
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival.
Br J Haematol
; 190(3): 394-404, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32232989
17.
Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline.
Br J Haematol
; 204(1): 86-107, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957111
18.
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 108-126, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37880821
19.
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance.
Br J Haematol
; 187(2): 174-184, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31236941
20.
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
Hematol Oncol
; 37(4): 352-359, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385336